期刊文献+

骨质疏松的诊断与鉴别诊断 被引量:8

The diagnosis and differential diagnosis of osteoporosis
原文传递
导出
摘要 世界卫生组织(WHO)推荐使用双能X线BMD测量仪(DXA)测定的骨密度诊断骨质疏松,以T≤-2.5为骨质疏松。对没有发生过骨折又有低骨量的人群(T>-2.5),采用骨折风险评估模型(FRAX)工具可以计算出每位个体发生骨折的绝对风险。面对每位"骨质疏松"患者,医师都应该做到低骨量的鉴别诊断、原发性或继发性骨质疏松的鉴别诊断、未来骨折风险的评估。 Summary:BMD determined by DXA was used in osteoporosis diagnosis recommende by WHO. A T-score of less than minus 2. 5 is diagnostic of osteoporosis. If a patient BMD T-score 〉 - 2. 5 without any fracture, FRAX tools may provide absolute risk of fracture in future. Every patient with "osteoporosis" in our clincal practice, should be discriminate the other causes than osteoporosis resulting low bone mass, and well differentiate as primary or secondary osteoporosis.
作者 夏维波 李梅
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第7期507-509,共3页 Chinese Journal of Practical Internal Medicine
关键词 骨质疏松 骨折风险评估 osteoporosis fracture risk evalution
  • 相关文献

参考文献12

二级参考文献17

  • 1夏维波.骨重建在维持骨强度中的意义[J].中华医学杂志,2006,86(6):363-365. 被引量:13
  • 2NIH consensus development panel on osteoporosis prevention,diagnosis,and therapy.Osteoporosis prevention,diagnosis,and therapy.JAMA,2001,285:785-795.
  • 3Watts NB.Bone quality:getting closer to a definition.J Bone Miner Res,2002,17:1148-1150.
  • 4Cummings SR,Karpf DB,Harris F,et al.Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs.Am J Med,2002,112:281-289.
  • 5Turner CH.Biomechanics of bone:determinants of skeletal fragility and bone quality.Osteoporos Int,2002,13:97-104.
  • 6Garnero P,Malmann D,Munoz F,et al.Long-term variability of bone markers of bone turnover in postmenopausal women and implicalions for their clinical utility.J Bone Miner Res,2002,17(Suppl 1) S299.
  • 7Eastell R,Barton I,Hannon RA,et al.Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.J Bone Miner Res,2003,18:1051-1056.
  • 8Delmas PD.How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis? Bone,2000,27:1-3.
  • 9Susan L,Greenspa N,Neil M,et al.Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate,hormone replacement therapy,or combination therapy:a three-year,double-blind,placebo-controlled,randomized clinical trial.J Clin Endo Metab,90:2762-2767.
  • 10NIH Consensus Development Panel on Osteoporosis Prevention, Diagngsis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA, 2001,285: 785-795.

共引文献68

同被引文献67

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部